0001246360-15-001571.txt : 20150319
0001246360-15-001571.hdr.sgml : 20150319
20150319165608
ACCESSION NUMBER: 0001246360-15-001571
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150317
FILED AS OF DATE: 20150319
DATE AS OF CHANGE: 20150319
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NxStage Medical, Inc.
CENTRAL INDEX KEY: 0001333170
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 043454702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 MERRIMACK STREET
CITY: LAWRENCE
STATE: MA
ZIP: 01843
BUSINESS PHONE: 978-687-4700
MAIL ADDRESS:
STREET 1: 350 MERRIMACK STREET
CITY: LAWRENCE
STATE: MA
ZIP: 01843
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burbank Jeffrey H
CENTRAL INDEX KEY: 0001341411
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51567
FILM NUMBER: 15713415
MAIL ADDRESS:
STREET 1: NXSTAGE MEDICAL INC
STREET 2: 439 SOUTH UNION STREET 5TH FLOOR
CITY: LAWRENCE
STATE: MA
ZIP: 01843
4
1
form.xml
PRIMARY DOCUMENT
X0306
4
2015-03-17
false
0001333170
NxStage Medical, Inc.
NXTM
0001341411
Burbank Jeffrey H
350 MERRIMACK STREET
LAWRENCE
MA
01843
true
true
false
false
Chief Executive Officer
Common Stock
2015-03-17
4
M
false
10000
2.11
A
886756
D
Common Stock
2015-03-17
4
S
false
10000
17.36
D
876756
D
Common Stock
2015-03-18
4
M
false
10000
2.11
A
886756
D
Common Stock
2015-03-18
4
S
false
10000
17.43
D
876756
D
Stock Option (Right to Buy)
2.11
2015-03-17
4
M
false
10000
0
D
2009-04-05
2016-03-04
Common Stock
10000
179274
D
Stock Option (Right to Buy)
2.11
2015-03-18
4
M
false
10000
0
D
2009-04-05
2016-03-04
Common Stock
10000
169274
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2014.
This represents the weighted average price for shares sold in multiple transactions at prices ranging from $16.83 to $17.48, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request.
This represents the weighted average price for shares sold in multiple transactions at prices ranging from $17.29 to $17.56, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request.
Aras Lapinskas, attorney-in-fact for Jeffrey Burbank
2015-03-19